Skip to search formSkip to main contentSkip to account menu

lomefloxacin

Known as: LFLX, Lomefloxacinum, (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid 
A synthetic broad-spectrum fluoroquinolone with antibacterial activity. Lomefloxacin inhibits DNA gyrase, a type II topoisomerase involved in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Background  Acute as well as chronic sun exposure induces biologically damaging effects in skin including photoageing and cancer… 
Highly Cited
2000
Highly Cited
2000
Highly Cited
2000
Highly Cited
2000
ABSTRACT The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment… 
Highly Cited
1998
Highly Cited
1998
Highly Cited
1997
Highly Cited
1997
The photolysis (> 320 nm) of the fluoroquinolone antibacterial agents lomefloxacin and fleroxacin results in the loss of their F3… 
Highly Cited
1997
Highly Cited
1997
To study the basis for the phototoxicity of quinolones, a class of synthetic antibacterials, the photodynamic ability to mediate… 
Highly Cited
1988
Highly Cited
1988
The in vitro activity of lomefloxacin (SC-47111; NY-198), a new difluorinated quinolone, was compared with those of ofloxacin… 
Highly Cited
1988
Highly Cited
1988
The pharmacokinetics of five dose levels of lomefloxacin (100, 200, 400, 600, and 800 mg) were examined in a single-dose, double…